Berberine Drug Interactions: What Human Studies Show

Yes, berberine can interact with prescription drugs. In a human study, two weeks of berberine slowed the breakdown of medicines that rely on three major liver enzymes: CYP3A4, CYP2D6 and CYP2C9. It has also raised blood levels of the transplant drug cyclosporine. Berberine can lower blood sugar too, so it may add to the effect of diabetes medicines. If you take any regular medicine, ask your pharmacist or prescriber before starting berberine, and tell them if you already take it.

Key takeaways

• Berberine 300 mg three times a day for 2 weeks reduced CYP2D6, CYP2C9 and CYP3A4 activity in healthy men (randomized crossover study).
• Exposure to the CYP3A4 test drug midazolam rose by about 40%.
• In kidney-transplant patients, berberine raised cyclosporine exposure by about a third, according to a 2026 review of the evidence.
• Higher-risk medicines are those where small changes in blood level matter, such as the transplant drugs cyclosporine and tacrolimus, and warfarin.
• Effects on blood sugar and blood pressure can add to the effects of medicines used for those conditions.
• NCCIH advises talking with a health care provider before using berberine if you take medicines.

What the human studies found

Liver enzymes (CYP450). Guo and colleagues ran a randomized crossover study in healthy men (Guo et al., 2012). After 2 weeks of berberine (300 mg three times daily), they gave standard test drugs that show how fast each enzyme works:

The study was small and done in healthy young men, but it is direct human evidence. When these enzymes slow down, drugs that depend on them can build up in the blood.

Cyclosporine. In six healthy men, berberine (0.3 g twice daily for 10 days) raised cyclosporine exposure by about 19% at one dose level but not at another (Xin et al., 2006). A 2026 review calls the effect in kidney-transplant recipients the best clinical example: cyclosporine exposure was about 34.5% higher and trough levels about 29% higher than in controls (Dumitru et al., 2026).

Which medicines need the most care

The FDA lists drugs that depend heavily on these enzymes. Examples include midazolam, simvastatin and tacrolimus (CYP3A), dextromethorphan and metoprolol (CYP2D6), and warfarin (CYP2C9) (FDA drug interaction tables). Few of these pairs have been tested with berberine directly. The risk is highest for:

• Narrow-margin drugs, where small level changes matter: transplant drugs such as cyclosporine and tacrolimus, and the blood thinner warfarin.
• Diabetes medicines, including insulin: berberine also lowers blood sugar, so hypoglycemia is a concern.
• Blood pressure medicines: the 2026 review lists additive blood pressure lowering, and QT prolongation, as possible effects that add to those of some medicines (Dumitru et al., 2026).
• Statins: several are cleared by CYP3A4. See our berberine and statins guide.

The review also notes that most other proposed interactions come from lab and animal work, not human studies. Product strength also varies between brands, which adds uncertainty about the dose actually taken.

What to do before starting

• Bring your full medicine list, including the berberine product label, to your pharmacist or prescriber.
• Do not stop or reduce a prescribed medicine to make room for berberine.
• If your clinician agrees to a trial, ask whether any drug levels, blood sugar or blood pressure should be checked more often at first.
• Stop and get advice if you notice dizziness, shakiness or sweating (possible low blood sugar), or unusual side effects from your usual medicines.
• Do not use berberine during pregnancy or breastfeeding, and do not give it to infants. NCCIH links it to harmful bilirubin buildup in newborns (NCCIH).

Related guides

For benefits, forms and dosing, see the berberine guide and berberine for cholesterol.

Sources

• Guo Y et al. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol, 2012 (PMID 21870106)
• Xin HW et al. Effects of berberine on the pharmacokinetics of cyclosporin A in healthy volunteers. 2006 (PMID 16541194)
• Dumitru CN et al. Berberine–drug interactions: narrative review. Pharmaceuticals, 2026 (PMID 42653808)
• FDA: Examples of drugs that interact with CYP enzymes and transporter systems
• NCCIH: Diabetes and Dietary Supplements